An Overview of Cancer Risk Assessment

References

• Paustenbach D J. The risk assessment of environmental hazards. Wiley, New York 1989
   Google Scholar
• Future risk: research strategies for the 1990s. United States Environmental Protection Agency Science Advisory Board. 1988, SAB-EC-88–040
   Google Scholar
• Slovic P, Fishhoff B, Lichtenstein S. Facts and fears: understanding perceived risk. Societal risk assessment: how safe is safe enough?, R Schwing, W A Albers, Jr. Plenum Press, New York 1980
   Google Scholar
• Covello V T, von Winterfeldt D, Slovic P. Communicating scientific information about health and environmental risks: problems and opportunities from a social and behavioral perspective. Uncertainties in risk assessment and risk management, V Covello, A Moghissi, V RR Uppulori. Plenum Press, New York, in press
   Google Scholar
• Mantel N, Bryan W. Safety testing of carcinogenic agents. J Natl Cancer Inst 1961; 27: 455–70
   PubMed Web of Science ®Google Scholar
• Environmental Protection Agency. Guidelines for carcinogen risk assessment. Federal Register 1986; 51: 33993–4003
   Google Scholar
• Office of Science and Technology Policy. Chemical carcinogens; notice of review of the science and its associated principles. Federal Register 1984; 49: 21594–661
   Google Scholar
• National Research Council, Committee on the Institutional Means for Assessment of Risks to Public Health. Risk assessment in the federal government: managing the process. National Academy Press, Washington, DC 1983
   Google Scholar
• Ames B N, Swirsky Gold L. Too many rodent carcinogens: mitogenesis increases mutagenesis. Science 1990; 249: 970–1
   PubMed Web of Science ®Google Scholar
• April 12, 1991, California Code of Regulations (CCR), Division 2. Chapter 3. Safe Drinking Water and Toxic Enforcement Act of 1986, Articles 6 and 7.
   Google Scholar
• March 9, 1988, Letter from Nelson N, Griesemer RA, Doull J to Thomas LM, Director of EPA. SAB-EHC-88–011
   Google Scholar
• Weisburger J H, Williams G M. Chemical carcinogens. Casarett and Doull's toxicology, the basic science of poisons, 2nd ed., J Doull, C D Klassen. Macmillan, New York 1980; 84–138
   Google Scholar
• Lewis S C, Lynch J R, Nikiforon A I. A new approach to deriving community exposure guidelines from “no-observed-adverse-effect-levels.”. Regul Toxicol Pharmacol 1990; 11: 314
   PubMed Web of Science ®Google Scholar
• Food Safety Council. Quantitative risk assessment. Food Cosmet Toxicol 1980; 18: 711–34
   Google Scholar
• Krewski D A, Brown C C. Carcinogenic risk assessment: a guide to the literature. Biometrics 1981; 37: 353–66
   PubMed Web of Science ®Google Scholar
• FDA Advisory Committee on Protocols for Safety Evaluation. Panel on carcinogenesis report on cancer testing in the safety evaluation of food additives and pesticides. Toxicol Appl Pharmacol 1971; 20: 419–38
   Google Scholar
• Crump K S, Hoel D G, Langley C H, Peto R. Fundamental carcinogenic processes and their implications for low dose risk assessment. Cancer Res 1976; 36: 2973–9
   PubMed Web of Science ®Google Scholar
• Gehring P J, Watanabe P G, Park C N. Risk of angiosarcoma in workers exposed to vinyl chloride and predicted for studies in rats. Toxicol Appl Pharmacol 1979; 49: 15–21
   PubMed Web of Science ®Google Scholar
• Guess H A, Crump K S, Peto R. Uncertainty estimates for low-dose extrapolations of animal carcinoge-nicity data. Cancer Res 1977; 37: 3475–83
   PubMed Web of Science ®Google Scholar
• Sielken R J, Jr. The use of the Hartley-Sielken model in low dose extrapolation. Toxicological risk assessment, D Clayson, D Krewski, I Munro. CRC Press, Boca Raton, Florida 1985
   Google Scholar
• Gibson J E. Risk assessment using a combination of testing and research results. Proceedings of the Third Annual Chemical Industries Institute of Toxicology Conference, “Formaldehyde Toxicity”, J E Gibson. Hemisphere, New York 1982
   Google Scholar
• Armitage P, Doll R. Stochastic models for carcinogenesis. Proceedings of the Fourth Berkeley Symposium on Mathematical Statistics and Probability. University of California Press, Berkeley 1961; 19–38
   Google Scholar
• Doll R. The age distribution of cancer: implications for models of carcinogenesis (with discussion). J R Statist Soc 1971; A 134: 133–66
   Google Scholar
• Howe R B, Crump K S. GLOBAL82: a computer program to extrapolate quantal animal toxicity data to low doses. Prepared for the Office of Carcinogenic Standards. U.S. Department of Labor, OSHA 1982, Contract 41USC252C3
   Google Scholar
• Krewski D A, Gaylor D W, Bickis M., Szyszkowicz M. A model-free approach to low-dose extrapolation. Environ Health Perspect 1991; 90: 279–85
   PubMed Web of Science ®Google Scholar
• Gehring P J, Ott M G, Park C N, Ramsey J C. Carcinogenic risk assessment: ethylene dibromide. Toxicol Appl Pharmacol 1979; 47: 411–4
   Google Scholar
• Krewski D A. Presentation at the Cancer Dose-Response Extrapolation Workshop. Sponsored by the Cancer Dose-Response Working Group of the International Life Sciences Institute, Washington, DC, September, 19–201991
   Google Scholar
• Gehring P J, Reitz R H. Park CN. Carcinogenic risk estimation for chloroform: an alternative to EPA's procedures. Food Cosmet Toxicol 1978; 16: 511–4
   Google Scholar
• Hawkins N C. Conservatism in maximally exposed individual (MEI) predictive exposure assessments: a first-cut analysis. Regul Toxicol Pharmacol 1991; 13: 000–00
   Google Scholar
• Schumann A M, Quast J F, Watanabe P G. The pharmacokinetics and macromolecular interactions of perchloroethylene in mice and rats as related to oncogenicity. Toxicol Appl Pharmacol 1980; 55: 207–19
   PubMed Web of Science ®Google Scholar
• Berenblum I. Tumour-formation following freezing with carbon dioxide snow. Br J Exp Pathol 1929; 10: 179ff
   Google Scholar
• USEPA. Cancer risk from outdoor exposure to air toxics. September, 1989, OAQPS External Review Draft
   Google Scholar
• Cornfield J. Carcinogenic risk assessment. Science 1977; 198: 693–9
   PubMed Web of Science ®Google Scholar
• Bogen K T. Cell proliferation kinetics and multistage cancer risk models. J Nad Cancer Inst 1989; 81: 267–77
   PubMed Web of Science ®Google Scholar
• Anderson M W, Hoel D G, Kaplan N L. A general scheme for the incorporation of pharmacokinetics in low-dose risk estimation for chemical carcinogenesis: example–-vinyl chloride. Toxicol Appl Pharma-col 1980; 55: 154–61
   PubMed Web of Science ®Google Scholar
• Reitz R H, Mendrala A L, Park C N, Andersen M, Guengerich E. FP. Incorporation of in vitro enzyme data into the physiologically-based pharmacokinetic (PB-PK) model for methylene chloride: implications for risk assessment. Toxicol Lett 1988; 43: 97–116
   PubMed Web of Science ®Google Scholar
• Moolgavkar S, Knudson H. AG, Jr. Mutation and cancer: a model for human carcinogenesis. J Natl Cancer Inst 1981; 66: 1037–52
   PubMed Web of Science ®Google Scholar
• Greenfield R E, Ellwein L, Cohen B. SM. A general theory of carcinogenesis. Carcinogenesis 1984; 5: 437–45
   PubMed Web of Science ®Google Scholar
• USEPA. Exposure factors handbook. Exposure Assessment Group, Office of Health and Environmental Assessment, Washington, DC 1989, EPA/600/8–89/043
   Google Scholar